Superior EFS and OS in Patients with Nonmetastatic Osteosarcoma and Unfavourable Prognosis when Adjuvant Mifamurtide is Combined with High-Dose Ifosfamide By Ogkologos - August 28, 2025 105 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the ISG/OS-2 and GEIS-33 studies Source RELATED ARTICLESMORE FROM AUTHOR A Short-Course Dose Escalation Strategy Could Improve Ability to Reach Target Dose of Adjuvant Abemaciclib in High-Risk Early-Stage HR-positive, HER2-negative Breast Cancer FDA Approves Ziftomenib for Relapsed or Refractory Acute Myeloid Leukaemia with a NPM1 Mutation NEPA Plus Dexamethasone Provide Superior Chemotherapy-Induced Nausea and Vomiting Prevention Compared with SoC Antiemetic Prophylaxis MOST POPULAR Mom Spots Strange Glow In Daughter’s Eye While Looking At Photo,... April 24, 2019 New Research Discovers How Scalp Cooling Helps Chemo Patients Keep Their... February 6, 2021 5-Year-Old Boy Surprised With Paycheck For Helping Electrical Company Fix His... January 21, 2022 Neoadjuvant Followed by Adjuvant Pembrolizumab Prolongs Event-Free Survival Compared to Adjuvant... March 8, 2023 Load more HOT NEWS Predicting future breast cancer with precision Women in science: Cancer research pioneers – part 2 Clinical Utility of ctDNA NGS for Detecting Actionable Alterations According ESCAT... Touching a nerve: How neuroscience could advance our understanding of cancer
